The team comprised researchers from the UK’s University of Cambridge and France’s École Nationale Supérieure des Mines and INSERM.
During the study, the researchers directly implanted a neurotransmitter into the brain of mice.
The device was tuned to deliver a native brain chemical to stop the progression of the seizure, upon detection of the first signals of a seizure.
The thin, organic films of the implantable electronic device were said to cause minimal damage to the brain, while their electronic properties allow medical applications.